News Kiniksa Pharmaceuticals, Ltd.

Equities

KNSA

BMG5269C1010

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
19.48 ^USD	-0.51%		-4.18%	+11.06%

May. 14	Transcript : Kiniksa Pharmaceuticals, Ltd. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:40 AM
Apr. 23	Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Kiniksa Pharmaceuticals, Ltd. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:40 AM	May. 14
Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference	May. 07	AQ
Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises	Apr. 23	MT
Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024	Apr. 23
Earnings Flash (KNSA) KINIKSA PHARMACEUTICALS Posts Q1 Revenue $79.9M, vs. Street Est of $78.5M	Apr. 23	MT
Kiniksa Pharmaceuticals, Ltd. Updates Earnings Guidance for 2024	Apr. 23	CI
Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution	Apr. 23	AQ
Kiniksa Pharmaceuticals, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23	CI
Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024	Apr. 16	AQ
Wedbush Adjusts Kiniksa Pharmaceuticals' PT to $30 From $28, Maintains Outperform Rating	Apr. 03	MT
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart	Apr. 02	AQ
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart	Apr. 02	CI
PRACTICE STATEMENT LETTER PROPOSED SCHEME OF ARRANGEMENT IN RESPECT OF: KINIKSA PHARMACEUTICALS, LTD - Form 8-K	Mar. 29	PU
Kiniksa Pharmaceuticals' Q4 Earnings, Revenue Increase	Feb. 28	MT
Transcript : Kiniksa Pharmaceuticals, Ltd., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
Earnings Flash (KNSA) KINIKSA PHARMACEUTICALS Reports Q4 Revenue $83.4M, vs. Street Est of $72.3M	Feb. 28	MT
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution	Feb. 28	AQ
Kiniksa Pharmaceuticals, Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 28	CI
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024	Feb. 21	AQ
Kiniksa Pharmaceuticals, Ltd. Provides Revenue Guidance for the Year 2024	Jan. 08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Kiniksa Pharmaceuticals, Ltd.

Equities

KNSA

BMG5269C1010

Summary

Filters